CLA-2-30:OT:RR:NC:N2:238
Mr. Colm Moynihan
NorthStar Healthcare Ltd.
3300 Cork Airport
Business Park, Kinsale Road
Cork, Ireland
RE: The tariff classification of Losartan Hydrochlorothiazide and Losartan Potassium in dosage form, from India
Dear Mr. Moynihan:
In your letter dated February 10, 2010, you requested a tariff classification ruling.
The first product, Losartan Hydrochlorothiazide, imported in tablet form, combines an angiotensin II receptor (type AT1) antagonist and a diuretic, hydrochlorothiazide. It is indicated for the treatment of hypertension.
The second product, Losartan Potassium, imported in tablet from, is an angiotensin II receptor (type AT1) antagonist. It is indicated for the treatment of hypertension.
The applicable subheading for the Losartan Hydrochlorothiazide tablets and Losartan Potassium tablets in dosage form will be 3004.90.9120, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Cardiovascular medicaments.” The rate of duty will be free.
Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/.
This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov.
This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177).
A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at (646) 733-3033.
Sincerely,
Robert B. Swierupski
Director
National Commodity Specialist Division